Grimes & Company, Inc. TONIX PHARMACEUTICALS HLDG C Transaction History

Grimes & Company, Inc.

  • $3.66 Billion
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 04, 2021
SELL
N/A
-20,700 Closed
0 $0
Q1 2021

May 12, 2021
BUY
N/A
20,700 New
20,700 $26,000
Track This Portfolio

Track Grimes & Company, Inc. Portfolio

Follow Grimes & Company, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Grimes & Company, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Grimes & Company, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email